The Indian budget proposes exempting seven rare disease drugs from import duties. This move aims to lower costs for expensive life-saving m...

Finance Minister Sitharaman announced the inclusion of six life-saving drugs in the concessional 5% duty slab to enhance access to critical...

You will always make large amounts of money in the market at all price points and you will make even larger amounts of money at all price p...

In another encouraging move for the pharma industry, the facilities in select ICMR laboratories will be made available for research by publ...

"An increase in the budgetary allocation from the current 1.8 per cent of the GDP to 2.5-3 per cent, as envisaged in the National Health Po...

To domestic manufacturing of bulk drug, the government Saturday announced a Rs 14,000 crore package that would incentivise production of ac...

Glenmark Pharmaceutical, GlaxoSmithKline, Cadila Healchcare and Lupin were also trading lower by 0.48 per cent, 0.26 per cent, 0.10 per cen...

Sectors like financial services, telecom, automobile and drugs are the top ten attractors of foreign investment in India, according to gove...

Buybacks have started gaining momentum after the 10% tax on investors’ earning dividends above Rs 10 lakh came into effect on April 1.

With companies announcing dividends before April 1, FIIs are aggressively buying back the shares they sold as part of the reverse arbitrage...

The focus, he said, within the Budget on 'Swachch Bharat' and linking this with health care has broad-based health issues in the country.

In its Budget proposals, the Commerce Ministry has sought "weighted average tax benefit of 400 per cent for R&D activities for the sector",...

"More the market rallies before the Budget, the higher is the extent of disappointment that might come about if the Budget does not deliver...

Hari Bhartia, co-chairman & managing director, Jubilant Organosys, in achat with ET Now, talks about pharma sector’s expectations from the ...

The excise duty incentives announced in this year’s budget may have been welcomed by the industry, but it has spelt doom for excise free zo...

This year’s Budget came as a welcome surprise for the domestic pharma industry.

The Planning Commission has mooted a proposal to significantly increase the allocation for the R&D fund to Rs 2,000 crore from Rs 150 crore...